Carl Anderson
Advertisement
Articles by Carl Anderson
Shedding light on common EMR concerns about privacy, government regulations, and data integrity.
Carl Anderson, senior consultant for Biologics Consulting Group, addresses the frequent overuse of Notes to File and concludes that documenting a mistake means absolutely nothing during an FDA inspection.
Advertisement
Latest Updated Articles
Key Updates to the 1572Published: May 23rd 2012 | Updated:
Note to File (NTF) is Not an FDA PanaceaPublished: March 1st 2008 | Updated:
The Ins and Outs of Electronic Medical RecordsPublished: September 1st 2008 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Takeda’s Phase III TIDES Trial Confirms Long-Term Efficacy and Safety of Qdenga Dengue Vaccine
2
Utilizing Tech Tools to Accelerate Drug Development
3
ACT Brief: Tech-Driven Data Strategies and Long-Term Vaccine Success
4
Streamlining Clinical Data to Reduce Site and Participant Burden
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
